Skip to main content
. 2017 Dec 18;98(2):389–395. doi: 10.4269/ajtmh.17-0501

Figure 2.

Figure 2.

Prevalence of ocular Chlamydia infection in children aged 0–5 years in communities randomized to standard (A) or enhanced (B) coverage. All communities received biannual mass azithromycin treatment in children less than 12 years of age.